Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125926481 | 12592648 | 1 | I | 20160718 | 20160726 | 20160726 | EXP | GN-STRIDES ARCOLAB LIMITED-2016SP010243 | STRIDES | CISSE M, SOUMAH M, TOUNKARA T, DIANE B, SACK F, BALDE H, CAMARA A, CAMARA A AND DOUMBOUYA A. LYELL SYNDROME WITH FATAL OUTCOME IN TWO PREGNANT WOMEN RECEIVING ANTIRETROVIRAL THERAPY IN GUINEA CONAKRY. J COSMET DERMATOL SCI APPL. 2013;3:135-138 | 0.00 | Y | 0.00000 | 20160726 | OT | GN | GN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125926481 | 12592648 | 1 | PS | NEVIRAPINE. | NEVIRAPINE | 1 | 200 MG, UNK | 78195 | 200 | MG | |||||||||
| 125926481 | 12592648 | 2 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | 78195 | ||||||||||||
| 125926481 | 12592648 | 3 | SS | Lamivudine and Zidovudine Tablets | LAMIVUDINEIDOVUDINE | 1 | UNK | 0 | |||||||||||
| 125926481 | 12592648 | 4 | SS | Lamivudine and Zidovudine Tablets | LAMIVUDINEIDOVUDINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125926481 | 12592648 | 1 | HIV infection |
| 125926481 | 12592648 | 2 | Prophylaxis against HIV infection |
| 125926481 | 12592648 | 3 | HIV infection |
| 125926481 | 12592648 | 4 | Prophylaxis against HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125926481 | 12592648 | HO |
| 125926481 | 12592648 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125926481 | 12592648 | Conjunctival erosion | |
| 125926481 | 12592648 | Dermatitis bullous | |
| 125926481 | 12592648 | Exposure during pregnancy | |
| 125926481 | 12592648 | General physical health deterioration | |
| 125926481 | 12592648 | Genital erosion | |
| 125926481 | 12592648 | Nikolsky's sign | |
| 125926481 | 12592648 | Oral mucosa erosion | |
| 125926481 | 12592648 | Premature delivery | |
| 125926481 | 12592648 | Skin erosion | |
| 125926481 | 12592648 | Skin exfoliation | |
| 125926481 | 12592648 | Toxic epidermal necrolysis | |
| 125926481 | 12592648 | Wound secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |